AH
The startup has developed a portable cryotherapy device for cervical cancer screening that operates independently of a power source, allowing healthcare practitioners to treat precancerous lesions in low-resource settings. This technology addresses the lack of accessible treatment options for women in clinics without reliable electricity, improving early intervention and patient outcomes.
Updated 20 months ago
Funding
$2.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EINCFunding rounds are not available yet.
Founders
Product
Features
- The startup has developed a portable cryotherapy device for cervical cancer screening that operates independently of a power source, allowing healthcare practitioners to treat precancerous lesions in low-resource settings. This technology addresses the lack of accessible treatment options for women in clinics without reliable electricity, improving early intervention and patient outcomes.